1. Home
  2. RVMD vs WAY Comparison

RVMD vs WAY Comparison

Compare RVMD & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • WAY
  • Stock Information
  • Founded
  • RVMD 2014
  • WAY 1999
  • Country
  • RVMD United States
  • WAY United States
  • Employees
  • RVMD N/A
  • WAY N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • WAY
  • Sector
  • RVMD Health Care
  • WAY
  • Exchange
  • RVMD Nasdaq
  • WAY Nasdaq
  • Market Cap
  • RVMD 7.4B
  • WAY 6.8B
  • IPO Year
  • RVMD 2020
  • WAY 2024
  • Fundamental
  • Price
  • RVMD $39.66
  • WAY $37.69
  • Analyst Decision
  • RVMD Strong Buy
  • WAY Strong Buy
  • Analyst Count
  • RVMD 12
  • WAY 12
  • Target Price
  • RVMD $68.67
  • WAY $41.45
  • AVG Volume (30 Days)
  • RVMD 1.7M
  • WAY 1.4M
  • Earning Date
  • RVMD 08-06-2025
  • WAY 08-06-2025
  • Dividend Yield
  • RVMD N/A
  • WAY N/A
  • EPS Growth
  • RVMD N/A
  • WAY N/A
  • EPS
  • RVMD N/A
  • WAY 0.15
  • Revenue
  • RVMD N/A
  • WAY $975,192,000.00
  • Revenue This Year
  • RVMD N/A
  • WAY $8.95
  • Revenue Next Year
  • RVMD $241.39
  • WAY $9.44
  • P/E Ratio
  • RVMD N/A
  • WAY $246.29
  • Revenue Growth
  • RVMD N/A
  • WAY 18.25
  • 52 Week Low
  • RVMD $29.17
  • WAY $20.26
  • 52 Week High
  • RVMD $62.40
  • WAY $48.11
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 49.08
  • WAY N/A
  • Support Level
  • RVMD $38.57
  • WAY N/A
  • Resistance Level
  • RVMD $42.40
  • WAY N/A
  • Average True Range (ATR)
  • RVMD 1.38
  • WAY 0.00
  • MACD
  • RVMD -0.16
  • WAY 0.00
  • Stochastic Oscillator
  • RVMD 28.46
  • WAY 0.00

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

Share on Social Networks: